The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man
- PMID: 973986
- PMCID: PMC1428933
- DOI: 10.1111/j.1365-2125.1976.tb00646.x
The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man
Abstract
Liver volume and the clearances of antipyrine and indocyanine green have been measured before and after administration of phenobarbitone (180 mg/day) for 3 weeks to ten healthy subjects. The measurement of liver volume by an ultrasound scanning technique yielded reproducible results which were consistent with predictions of liver size by allometric methods. Before phenobarbitone, antipyrine clearance correlated with liver volume, but there was no correlation between indocyanine green clearance and liver volume. Phenobarbitone administration increased the clearance of antipyrine significantly by 90 +/- 14% but there was no significant change in indocyanine green clearance or liver volume. After phenobarbitone the correlation between antipyrine clearance and liver volume persisted. There was no correlation between indocyanine green clearance and liver volume. These results suggest that in non-medicated subjects some of the difference in antipyrine clearance is due to difference in functional hepatic parenchymal mass and that phenobarbitone increases the drug metabolising capacity per unit of hepatic mass but not total liver size.
Similar articles
-
Proceedings: The relationships between liver volume and the disposition of antipyrine and indocyanine green before and after phenobarbitone treatment.Br J Pharmacol. 1975 Oct;55(2):263P. Br J Pharmacol. 1975. PMID: 1201403 Free PMC article. No abstract available.
-
The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.Clin Pharmacol Ther. 1976 Jul;20(1):81-9. doi: 10.1002/cpt197620181. Clin Pharmacol Ther. 1976. PMID: 1277728
-
Comparative evaluation of the effects of labetalol, verapamil and diltiazem on antipyrine and indocyanine green clearances.J Clin Pharmacol. 1989 Oct;29(10):891-5. doi: 10.1002/j.1552-4604.1989.tb03250.x. J Clin Pharmacol. 1989. PMID: 2592580 Clinical Trial.
-
Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery.Anaesth Intensive Care. 2000 Aug;28(4):375-85. doi: 10.1177/0310057X0002800404. Anaesth Intensive Care. 2000. PMID: 10969363 Review.
-
Influence of age and smoking on drug kinetics in man: studies using model compounds.Clin Pharmacokinet. 1980 Jul-Aug;5(4):309-19. doi: 10.2165/00003088-198005040-00001. Clin Pharmacokinet. 1980. PMID: 6994978 Review.
Cited by
-
Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy.Br J Clin Pharmacol. 1988 Sep;26(3):253-9. doi: 10.1111/j.1365-2125.1988.tb05274.x. Br J Clin Pharmacol. 1988. PMID: 3179165 Free PMC article.
-
Liver size and indices of drug metabolism in epileptics.Br J Clin Pharmacol. 1978 Sep;6(3):273-8. doi: 10.1111/j.1365-2125.1978.tb04597.x. Br J Clin Pharmacol. 1978. PMID: 687506 Free PMC article.
-
Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.Eur J Clin Pharmacol. 1983;25(2):215-22. doi: 10.1007/BF00543794. Eur J Clin Pharmacol. 1983. PMID: 6628504
-
Disposition of antipyrine in patients with extensive metastatic liver disease.Eur J Clin Pharmacol. 1992;42(5):465-9. doi: 10.1007/BF00314851. Eur J Clin Pharmacol. 1992. PMID: 1606991
-
Clinical pharmacokinetics of nicotine.Clin Pharmacokinet. 1987 Jan;12(1):30-40. doi: 10.2165/00003088-198712010-00003. Clin Pharmacokinet. 1987. PMID: 3545615 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources